Janssen Gets EU Approval for Prostate Cancer Drug Akeega
Janssen Pharmaceuticals, a division of Johnson & Johnson, received European Commission marketing authorization for its prostate cancer drug Akeega (niraparib and abiraterone acetate), the first...